Navigation Links
UTMB awarded $4.4M to develop universal flu vaccine

Researchers at the University of Texas Medical Branch are working to create a universal flu vaccine one that could eliminate the need for an annual flu shot.

If approved for general use, the vaccine would be a public health breakthrough not only in preventing influenza in the United States but most importantly in the developing world, where the virus can have much more devastating effects due to the challenge of vaccinating these populations every year.

Thanks to a $4.4 million grant from the National Institute of Allergy and Infectious Diseases, UTMB researchers and Seattle-based biotechnology company Etubics Corporation plan to construct, produce and test a vaccine containing various antigens of the A and B strains of influenza.

If successful, clinicians could have a vaccine that recognizes all influenza viruses, not just a single type, ready for patients within five years, according to Dr. Frank Jones, chairman and chief executive officer of Etubics.

Co-principal investigator Dr. Slobodan Paessler, a professor in the UTMB Department of Pathology and director of the Preclinical Studies Core in the Galveston National Laboratory, said that UTMB has one of the most comprehensive university-based vaccine development programs in the world.

"UTMB also has broad capabilities in the area of vaccine development and infectious diseases," he said. "We believe these resources provide an excellent infrastructure to support this project as it moves forward through the vaccine development pathway to ultimately become a licensed vaccine."

Vaccine development is one of the most ambitious of scientific undertakings, often taking several years and at least a half billion dollars for a vaccine to go from the lab to clinical trials to common use. There are only about 50 vaccines approved worldwide today.

UTMB researchers have earned worldwide recognition for their contributions to the field, and today are focusing on developing vaccines not only for infectious diseases but also aging-related chronic illnesses such as heart disease, diabetes, cancer and Alzheimer's disease.


Contact: Kristen Hensley
University of Texas Medical Branch at Galveston

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
11. EMBO Gold Medal 2012 awarded to Jiri Friml
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology: